After obtaining the analysis results of the oncogenic potential of ZIC2 and its remarkable correlation with immune infiltration in oral cancer, we were curious about drugs which might show improved efficacy in oral cancer patients with high expression of ZIC2 and scored the drug sensitivity. The gene discussed is ZIC2; the disease is lip and oral cavity carcinoma.